Records containing: Pneumococcal Conjugate Vaccine
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-04-26A PHASE 3 OPEN-LABEL TRIAL TO ASSESS THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN INFANTS AND YOUNG CHILDREN IN CHINA WHO ARE NAIVE TO PNEUMOCOCCAL VACCINATION
-
CLINICAL_TRIALS study record update · 2023-10-30Population-based Nationwide Study on Invasive Pneumococcal Infections Among Children (0-18 Years) in France
-
CLINICAL_TRIALS study record update · 2022-12-27National Observatory of Bacterial Meningitis in Children and Newborns
-
CLINICAL_TRIALS study record update · 2020-05-29Paediatric Post Pneumococcal Conjugate Vaccine Nasopharyngeal Carriage Study
-
CLINICAL_TRIALS study record update · 2014-04-21A Phase 3, Open-Label, Single-Arm Trial Evaluating the Safety, Tolerability, and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine in Children With Sickle Cell Disease Previously Immunized With 23vPS Vaccine
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-09-20A Phase 3, Randomized, Modified Double-Blind, Active-Controlled Trial Evaluating The Safety, Tolerability, And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine In Japanese Elderly Adults Aged 65 Years Old And Older Who Are Naive To Pneumococcal Vaccine
-
CLINICAL_TRIALS study record update · 2011-11-11Characterization of the Prevnar Infant Long-term Immune Response vs a Prevnar Naive Cohort
-
CLINICAL_TRIALS study record update · 2011-05-12A PHASE 3, RANDOMIZED, ACTIVE-CONTROLLED, DOUBLE-BLIND TRIAL EVALUATING THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS GIVEN WITH ROUTINE PEDIATRIC VACCINATION IN TAIWAN